2009
DOI: 10.1016/j.mcn.2009.01.002
|View full text |Cite
|
Sign up to set email alerts
|

Reverse glial glutamate uptake triggers neuronal cell death through extrasynaptic NMDA receptor activation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
63
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 72 publications
(65 citation statements)
references
References 51 publications
2
63
0
Order By: Relevance
“…Treatment with low concentrations of memantine protects against NMDA-induced toxicity in vitro Papadia et al, 2008;Gouix et al, 2009;Bordji et al, 2010), as well as neurotoxicity and learning deficits in chemical lesion models (Misztal et al, 1996;Lee et al, 2006) and neurodegenerative disease models (Okamoto et al, 2009;Martinez-Coria et al, 2010;. However, higher doses of memantine produce deleterious effects (Chen et al, 1998;Chen and Lipton, 2006;Okamoto et al, 2009).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Treatment with low concentrations of memantine protects against NMDA-induced toxicity in vitro Papadia et al, 2008;Gouix et al, 2009;Bordji et al, 2010), as well as neurotoxicity and learning deficits in chemical lesion models (Misztal et al, 1996;Lee et al, 2006) and neurodegenerative disease models (Okamoto et al, 2009;Martinez-Coria et al, 2010;. However, higher doses of memantine produce deleterious effects (Chen et al, 1998;Chen and Lipton, 2006;Okamoto et al, 2009).…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, extrasynaptic NMDARs shut off cell survival pathways (Hardingham et al, 2002), induce mitochondrial dysfunction (Gouix et al, 2009), and activate pro-death molecules (Léveillé et al, 2010). Thus far, disparate synaptic/extrasynaptic NMDAR signaling has been investigated in cortical (CTX) and hippocampal neurons; it is unknown whether nonglutamatergic subcortical projection neurons, such as GABAergic medium-sized spiny projection neurons of the striatum (MSNs; Ͼ90% of striatal cells), follow the same pattern.…”
Section: Introductionmentioning
confidence: 99%
“…To activate synaptic NMDARs, we used a stimulation paradigm that we have previously characterized on cortical neurons (Gouix et al, 2009). Coapplication of bicuculline (50 M), a GABAA receptor antagonist, and 4AP (2.5 mM), a weak potassium-channel blocker, induces synchronous bursts of action potentials leading to synaptic NMDAR activation (Hardingham and Bading, 2002).…”
Section: Synaptic Nmdar Activationmentioning
confidence: 99%
“…Immunocytochemistry was performed as described by Gouix et al (2009). To evaluate the proportion of p-ERK-positive neurons, we performed colabeling for p-ERK (1:100; Santa Cruz Biotechnology) and a neuronal marker (1:500; Sigma-Aldrich).…”
Section: Immunocytochemistrymentioning
confidence: 99%
“…Many studies have established that synaptic NMDAR activation induced an upregulation of key pathways (ERK, CaMK), transcription factors (CREB), or prosurvival genes (BDNF). Conversely, activation of extrasynaptic NMDAR was shown to cause a loss of mitochondrial membrane potential (Hardingham et al, 2002;Léveillé et al, 2008;Gouix et al, 2009), and to have opposite effects on synaptic NMDAR-activated CREB function (Hardingham et al, 2002;Soriano and Hardingham, 2007;Mulholland et al, 2008), ERK pathway (Ivanov et al, 2006;Gouix et al, 2009), or BDNF expression (Vanhoutte and Bading, 2003). Very recently, extrasynaptic NMDARs were also shown to be implicated in the pathogenesis of Huntington's disease (Okamoto et al, 2009;Milnerwood et al, 2010).…”
mentioning
confidence: 99%